Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP801129.RAw0BR7DZYxFZjQh_oc28sOg9ISfte7z-4S2Y1WXz2XrY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP801129.RAw0BR7DZYxFZjQh_oc28sOg9ISfte7z-4S2Y1WXz2XrY130_assertion type Assertion NP801129.RAw0BR7DZYxFZjQh_oc28sOg9ISfte7z-4S2Y1WXz2XrY130_head.
- NP801129.RAw0BR7DZYxFZjQh_oc28sOg9ISfte7z-4S2Y1WXz2XrY130_assertion description "[Patients with the GSTT1-null genotype, however, showed more frequent grade III-IV chemotherapy-related toxicities, including leukocytopenia [odds ratio (OR)=3.1; 95% confidence interval (95%CI), 1.2-8.0; P=0.025], fever (OR=5.3; 95% CI, 1.4-19.7; P=0.009), and mucositis (OR=4.6; 95% CI, 1.4-15.1; P=0.012).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801129.RAw0BR7DZYxFZjQh_oc28sOg9ISfte7z-4S2Y1WXz2XrY130_provenance.
- NP801129.RAw0BR7DZYxFZjQh_oc28sOg9ISfte7z-4S2Y1WXz2XrY130_assertion evidence source_evidence_literature NP801129.RAw0BR7DZYxFZjQh_oc28sOg9ISfte7z-4S2Y1WXz2XrY130_provenance.
- NP801129.RAw0BR7DZYxFZjQh_oc28sOg9ISfte7z-4S2Y1WXz2XrY130_assertion SIO_000772 20303013 NP801129.RAw0BR7DZYxFZjQh_oc28sOg9ISfte7z-4S2Y1WXz2XrY130_provenance.
- NP801129.RAw0BR7DZYxFZjQh_oc28sOg9ISfte7z-4S2Y1WXz2XrY130_assertion wasDerivedFrom befree-2016 NP801129.RAw0BR7DZYxFZjQh_oc28sOg9ISfte7z-4S2Y1WXz2XrY130_provenance.
- NP801129.RAw0BR7DZYxFZjQh_oc28sOg9ISfte7z-4S2Y1WXz2XrY130_assertion wasGeneratedBy ECO_0000203 NP801129.RAw0BR7DZYxFZjQh_oc28sOg9ISfte7z-4S2Y1WXz2XrY130_provenance.